Mechanism of Pharmacological Action
The pharmacological effects of Niclosamidum are based on two key processes leading to helminth death in the intestinal lumen:
- Induction of pronounced muscle paralysis in flatworms, depriving them of the ability to hold onto the host's intestinal wall.
- Reduction of the protective properties of the parasite's tegument, rendering it vulnerable to human gastrointestinal digestive enzymes.
Pharmacokinetic Profile
An important feature of this compound is its ability to act predominantly locally within the intestinal lumen.
- The drug is poorly absorbed from the GI tract, ensuring its maximum concentration directly at the site where tapeworms are localized.
- Due to minimal systemic absorption, the substance hardly enters the systemic circulation, concentrating precisely where required to exert its therapeutic effect.
Clinical Indications
The medical application of Niclosamidum covers severe intestinal infections caused by tapeworms:
- Taeniasis (beef tapeworm infection / Taenia saginata) — the drug serves as the primary drug of choice ("most effective agent");
- Diphyllobothriasis, caused by the broad fish tapeworm;
- Hymenolepiasis, caused by the dwarf tapeworm (Hymenolepis nana).
In these clinical settings, phenasal achieves eradication of the pathogens from the body.
Critical Contraindication and Risks
The use of Niclosamidum requires strict differential diagnosis prior to therapy due to an absolute restriction:
- Taeniasis (pork tapeworm infection / Taenia solium) is a critical contraindication for administration.
- Reason for restriction: the drug digests the parasite's proglottids and releases eggs into the intestinal lumen, dramatically increasing the risk of developing a dangerous complication — cysticercosis.